FXR Protein (Farnesoid X Receptor)

FXR Protein (Farnesoid X Receptor)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FXR Protein (Farnesoid X Receptor)</th>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Amino Acids</td>
</tr>
<tr>
<td class="label">FXRα1</td>
<td>472</td>
</tr>
<tr>
<td class="label">FXRα2</td>
<td>435</td>
</tr>
<tr>
<td class="label">FXRβ</td>
<td>458</td>
</tr>
<tr>
<td class="label">FXRγ</td>
<td>418</td>
</tr>
<tr>
<td class="label">Gene Variant</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">NR1H4 variants</td>
<td>Altered bile acid sensing</td>
</tr>
<tr>
<td class="label">FXR expression</td>
<td>Modified function</td>
</tr>
<tr>
<td class="label">FGF19 signaling</td>
<td>Metabolic changes</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">RXR</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">SHP</td>
<td>Coregulator</td>
</tr>
<tr>
<td class="label">PGC-1α</td>
<td>Coactivator</td>
</tr>
<tr>
<td class="label">NCoR/SMRT</td>
<td>Corepressor</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

FXR Protein (Farnesoid X Receptor)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FXR Protein (Farnesoid X Receptor)</th>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Amino Acids</td>
</tr>
<tr>
<td class="label">FXRα1</td>
<td>472</td>
</tr>
<tr>
<td class="label">FXRα2</td>
<td>435</td>
</tr>
<tr>
<td class="label">FXRβ</td>
<td>458</td>
</tr>
<tr>
<td class="label">FXRγ</td>
<td>418</td>
</tr>
<tr>
<td class="label">Gene Variant</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">NR1H4 variants</td>
<td>Altered bile acid sensing</td>
</tr>
<tr>
<td class="label">FXR expression</td>
<td>Modified function</td>
</tr>
<tr>
<td class="label">FGF19 signaling</td>
<td>Metabolic changes</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">RXR</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">SHP</td>
<td>Coregulator</td>
</tr>
<tr>
<td class="label">PGC-1α</td>
<td>Coactivator</td>
</tr>
<tr>
<td class="label">NCoR/SMRT</td>
<td>Corepressor</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

FXR (Farnesoid X Receptor, also known as NR1H4) is a nuclear receptor that functions as the primary sensor of bile acids in the body[@makishima1999]. FXR regulates bile acid synthesis, transport, and metabolism, while also playing important roles in glucose homeostasis, lipid metabolism, and inflammatory responses[@parks1999]. In the central nervous system, FXR is expressed in [neurons](/entities/neurons) and glial cells, where it modulates neuroinflammation, cholesterol metabolism, and synaptic plasticity—making it a potential therapeutic target for neurodegenerative diseases[@huang2016].

Protein Structure

FXR has the characteristic nuclear receptor domain architecture with several isoforms:

Isoforms

Domain Architecture

FXR Protein Structure
┌─────────────────────────────────────────────────────┐
│ AF-1 │ DBD │ Hinge │ LBD │ AF-2 │
│(1-50) │(51-110) │(111-180) │(181-400) │(401-472)│
└─────────────────────────────────────────────────────┘

DBD: Two C4-type zinc fingers
LBD: Ligand-binding domain with hydrophobic pocket

• AF-1 Domain: N-terminal activation function, isoform-specific
• DNA-binding Domain: Two zinc fingers for direct repeat-1 (DR-1) response elements
• Hinge Region: Flexible linker for conformational changes
• Ligand-binding Domain: Binds primary bile acids (CDCA > DCA > CA > UDCA)
• AF-2 Helix: Completes the transcriptionally active conformation

Normal Biological Function

Bile Acid Metabolism

FXR is the master regulator of bile acid homeostasis:

• Activates CYP7A1 repression via FGF19 signaling
• Inhibits bile acid synthesis when levels are high
• Coordinates hepatic and intestinal signaling

• Regulates BSEP (bile salt export pump)
• Controls NTCP (sodium taurocholate cotransporter)
• Modulates OSTα/β (organic solute transporter)

• FGF19/15 signaling from intestine to liver
• Coordinated regulation of bile acid pool

Metabolic Regulation

Glucose Homeostasis:

• Enhances insulin sensitivity
• Suppresses gluconeogenesis
• Improves β-cell function

• Inhibits de novo lipogenesis
• Reduces triglycerides
• Modulates VLDL secretion

• Inhibits [NF-κB](/entities/nf-kb) transcription
• Reduces inflammatory cytokines
• Protects against metabolic inflammation

Role in Neurodegeneration

Alzheimer's Disease

FXR has emerged as a significant player in AD pathogenesis:

Cholesterol Metabolism:

• FXR regulates cholesterol metabolism in the brain
• Alters [APOE](/proteins/apoe) expression and lipidation
• Affects [amyloid precursor protein](/entities/app-protein) processing

• FXR agonists reduce amyloid-β toxicity in models[@zhang2019]
• Improves synaptic plasticity and memory
• Reduces oxidative stress

• Suppresses microglial activation
• Reduces inflammatory cytokine expression
• Protects against neuroinflammation

• FXR agonists in clinical development for AD
• Combination approaches with other targets
• Gene expression modulators

Parkinson's Disease

FXR provides neuroprotection in PD models:

Dopaminergic Neurons:

• Protects against 6-OHDA toxicity
• Reduces mitochondrial dysfunction
• Enhances neuronal survival

• Modulates glial cell activation
• Suppresses inflammatory responses
• Reduces dopaminergic neuron loss

• FXR agonists show promise in preclinical studies
• Obeticholic acid (OCA) being investigated
• Cholesterol-lowering effects beneficial

Amyotrophic Lateral Sclerosis

• Lipid metabolism modulation
• Anti-inflammatory effects
• Motor neuron protection

Multiple Sclerosis

• Myelin lipid regulation
• Anti-inflammatory properties
• Demyelination protection

Genetic Associations

Protein Interactions

Transcriptional Complexes

Target Genes

• Bile Acid Metabolism: CYP7A1, BSEP, NTCP, OSTα/β
• Lipid Metabolism: ApoC-II, ApoC-III, PLTP
• Glucose Metabolism: PEPCK, G6Pase
• Transport: OSTα, OSTβ, MRP3

Expression Patterns in the Brain

Cellular Distribution

• Neurons: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum
• [Astrocytes](/entities/astrocytes): Moderate expression
• [Microglia](/cell-types/microglia-neuroinflammation): Lower expression, increases with activation
• Oligodendrocytes: Present but lower levels

Regional Expression

• Highest in cerebral cortex and hippocampus
• Moderate in basal ganglia
• Lower in brainstem

Regulation

• Bile Acid Levels: Ligand-dependent activation
• Inflammatory Signals: Suppressed by NF-κB
• Metabolic State: Regulated by nutritional status

Therapeutic Implications

FXR Agonists

• FDA-approved for PBC
• Being studied for NASH and AD
• Good safety profile

• Research compound
• High potency
• Poor brain penetration

• Improved safety profile
• Being studied for metabolic diseases

Challenges

• Peripheral Effects: Liver and gastrointestinal actions
• Brain Penetration: Limited for CNS applications
• Pruritus: Side effect of potent agonists

Alternative Approaches

• FGF19 Analogs: Target CNS expression
• Gene Therapy: Tissue-specific modulation
• Small Molecule Modulators: Selective CNS effects

Related Pathways

• [Bile Acid Metabolism](/mechanisms/bile-acid-metabolism)
• [Cholesterol Metabolism](/data/pages/cerebral_cholesterol_metabolism)
• [NF-κB Signaling](/mechanisms/nf-kb-signaling-neuroinflammation)
• [FGF Signaling](/mechanisms/fgf-signaling-pathway)
• [Neuroinflammation](/mechanisms/neuroinflammation)

Related Proteins

• [NR1H4 Gene (FXRα)](/genes/nr1h4)
• [SHP (NR0B2) Gene](/genes/nr0b2)
• [RXRα Protein](/proteins/rxra-protein)
• [FGF19 Protein](/proteins/fgf19-protein)
• [APOE Protein](/proteins/apoe-protein)

See Also

• [Bile Acid Metabolism](/mechanisms/bile-acid-metabolism)
• [NF-κB Signaling](/mechanisms/nf-kb-signaling-neuroinflammation)
• [FGF Signaling](/mechanisms/fgf-signaling-pathway)
• [Neuroinflammation](/mechanisms/neuroinflammation)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References